Abstracts

Safety of Tenofovir Alafenamide in Renal Impairment

Background: Tenofovir (TFV) is renally eliminated, and the prodrug, tenofovir disoproxil fumarate (TDF), has been associated with renal toxicity and reduced bone mineral density (BMD), and must be dose adjusted in patients with estimated glomerular filtration rate (eGFR) < 50mL/min. Tenofovir alafenamide (TAF) is a novel prodrug of TFV that is not renally eliminated and…

Elevated Nonclassical Monocytes and Urine Fibrotic Markers in HIV Albuminuria

Background: Presence of albuminuria (ALB) predicts an accelerated loss in renal function. Rates of ALB are high among HIV-infected individuals on antiretroviral therapy (ART). We investigated the relationship of monocyte (MO) subsets and urine inflammatory and fibrotic markers to ALB in stable HIV-infected subjects on ART. Methods: Cross-sectional analyses on Hawaii Aging with HIV-CVD cohort…

Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study

Background: HIV-associated chronic immune activation and inflammation may contribute to increased risk for kidney disease among HIV-infected (HIV+) individuals, even after viral suppression. We examined associations between inflammatory processes and kidney function in treated and virally suppressed HIV+ and HIV– men from the Multicenter AIDS Cohort Study. Methods: Glomerular filtration rate (GFR) was directly measured…

Risk Factors for Acute Allograft Rejection in HIV Positive Kidney Transplant Recipients

Background: Kidney transplantation (KT) of HIV positive patients has transformed the management of end-stage kidney disease in this population. Although favourable outcomes have been reported, patients experience high rates of acute allograft rejection (AR). We examined factors associated with AR in the first year post-KT, with particular emphasis on the choice of calcineurin inhibitor (CNI)…

Survival in HIV-Positive Transplant Recipients Compared to Matched Registry Controls

Background: We designed a 21-center study to test the hypothesis that immunosuppression does not accelerate HIV disease progression in transplant recipients with relatively intact immune systems and suppressed viremia. We further hypothesized that HIV+ patients would be higher risk but acceptable transplant candidates, similar to other higher risk groups. We previously described 3-year outcomes in…

Risk Factors for Airflow Obstruction Among HIV+ Individuals in Nairobi, Kenya

Background: Antiretroviral therapy (ART) and prolonged survival are shifting the spectrum of HIV-related pulmonary complications toward a greater burden of chronic lung disease (CLD). In developing countries, this impacts HIV+ individuals at all ages, including adolescent survivors of vertically-acquired HIV, yet risk factors for CLD are incompletely understood. We hypothesized that vertically-acquired HIV, indoor biofuel…

Pulmonary Complications of HIV-1 in Youth: The PHACS AMP Study

Background: Perinatally HIV-infected (PHIV) youth may have an increased risk of asthma compared to perinatally HIV-exposed uninfected (PHEU) youth, particularly after antiretroviral therapy. Prior studies have diagnosed asthma by history, asthma medications, and physician examination. The present multi-center study used pulmonary function tests (PFTs) to compare the prevalence of obstructive (OBS) and restrictive (RES) pulmonary…

Distinct Airway Methylation and Gene Expression Profiles in HIV-Associated COPD

Background: Recent studies have identified an increased prevalence of chronic obstructive pulmonary disease (COPD) in HIV. Clinical manifestations of COPD in the HIV population appear to be more severe and develop earlier than in HIV-uninfected individuals. The underlying mechanism behind accelerated COPD in HIV is unknown. We hypothesize that airway epithelial DNA methylation and gene…

Alcohol, Substance Use, and Smoking Associations With Lipoatrophy and Lipohypertrophy

Background: We sought to examine the associations between alcohol and substance use with body morphology. Unlike many previous studies, we did not combine lipoatrophy and lipohypertrophy outcomes, and were able to take into account correlated behavioral factors such as substance abuse, physical activity, and smoking. Methods: Eligible patients were in CNICS at 6 sites and…